Ci Investments Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Ci Investments Inc.

$26.3 Billion
Q3 2024

A detailed history of Ci Investments Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Ci Investments Inc. holds 3,597 shares of ALNY stock, worth $911,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,597

Previous 3,622 0.69%

Holding current value

$911,299

Previous $880,000 12.39%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$233.81 - $287.01 $5,845 - $7,175	-25 Reduced 0.69%	3,597 $989,000
Q2 2024 Aug 12, 2024	SELL	$143.31 - $247.0 $38,550 - $66,443	-269 Reduced 6.91%	3,622 $880,000
Q1 2024 May 13, 2024	BUY	$146.51 - $198.2 $225,625 - $305,228	1,540 Added 65.5%	3,891 $582,000
Q4 2023 Feb 12, 2024	SELL	$151.41 - $196.57 $44,968 - $58,381	-297 Reduced 11.22%	2,351 $450,000
Q3 2023 Nov 13, 2023	SELL	$170.77 - $211.65 $57,549 - $71,326	-337 Reduced 11.29%	2,648 $469,000
Q2 2023 Aug 11, 2023	BUY	$185.01 - $212.05 $250,688 - $287,327	1,355 Added 83.13%	2,985 $567,000
Q1 2023 May 12, 2023	BUY	$182.66 - $235.53 $162,750 - $209,857	891 Added 120.57%	1,630 $327,000
Q4 2022 Feb 10, 2023	BUY	$185.53 - $241.31 $64,007 - $83,251	345 Added 87.56%	739 $176,000
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $18,841 - $31,552	136 Added 52.71%	394 $79,000
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $52,262 - $73,471	-434 Reduced 62.72%	258 $38,000
Q1 2022 May 12, 2022	BUY	$127.18 - $173.91 $6,231 - $8,521	49 Added 7.62%	692 $113,000
Q4 2021 Feb 11, 2022	BUY	$159.56 - $209.29 $20,104 - $26,370	126 Added 24.37%	643 $109,000
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $87,760 - $107,396	517 New	517 $98,000
Q3 2020 Nov 09, 2020	SELL	$121.19 - $165.49 $246,742 - $336,937	-2,036 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$104.21 - $156.44 $212,171 - $318,511	2,036 New	2,036 $302,000
Q1 2020 Aug 07, 2020	SELL	$93.12 - $133.99 $299,846 - $431,447	-3,220 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$74.51 - $124.23 $239,922 - $400,020	3,220 New	3,220 $371,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Alnylam Pharmaceuticals, Inc. Transaction History